Responses

Download PDFPDF
Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re:Questionable PREP selection

    I find it intriguing that the eCigarette samples found no discernible nicotine content. I have personally conducted my own (albeit uncontrolled) blind-study using a lower nicotine brand (12mg) of "e-cigarette Juice" and a higher nicotine content brand (36mg).

    The two brands were largely identical in terms of content and taste but the differences in terms of their satisfaction in relieving the stress of not smoking...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Questionable PREP selection

    The products mentioned in the study appear to be selected specifically selected for their low nicotine content. While the paper succeeds in adapting existing methodology for traditional tobacco products to these new classes of smokeless tobacco products, only testing PREPs containing a low amount of nicotine understates their potential as a smoking cessation aid.

    Star Scientific Inc. (manufacturers of Ariva) pro...

    Show More
    Conflict of Interest:
    None declared.